These findings highlight that the dysregulation of inflammasome activation, with subsequent IL-1β and IL-18 production, is crucial in tumourigenesis, the inflammasome molecules representing potential valuable prognostic melanoma biomarkers [94]. This evidence concerns the gene IL1B and melanoma.